See more : National Australia Bank Limited (NAUBF) Income Statement Analysis – Financial Results
Complete financial analysis of Hebei Jianxin Chemical Co., Ltd. (300107.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hebei Jianxin Chemical Co., Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Itron, Inc. (ITRI) Income Statement Analysis – Financial Results
- Domtar Corporation (UFS) Income Statement Analysis – Financial Results
- Donear Industries Limited (DONEAR.NS) Income Statement Analysis – Financial Results
- abrdn Property Income Trust Limited (API.L) Income Statement Analysis – Financial Results
- Zespól Elektrowni Patnów-Adamów-Konin S.A. (ZEP.WA) Income Statement Analysis – Financial Results
Hebei Jianxin Chemical Co., Ltd. (300107.SZ)
About Hebei Jianxin Chemical Co., Ltd.
Hebei Jianxin Chemical Co., Ltd. researches and develops, manufactures, and sells dyes intermediates in China. It offers metanilic acid, aniline-2, 5-disulfonic acid monosodium salt, 3- diethylaminophenol, m-aminophenol, sulfanilic acid, ODB-1, ODB-2, R-04, EBA, BBA, MMD, DPA, DBSP, BON, and n-butyl bromide. The company also provides 3,3'-dinitrodiphenyl sulfone; 3,3'-diamino diphenyl sulphone; 4,4'-dichloro diphenyl sulphone; 4,4'-diamino diphenyl sulfone; and m-trihydroxybenzene. Its products are used as intermediates for dyes, medicine, fiber, pesticide, dyestuffs, and synthesizing health care products; OBA for paper; color formers for thermal and carbonless paper; and developer and sensitizer for thermal paper. The company's products are also used as alkylating agent, solvent, and extracting agent for rare elements and organic synthesis; materials for curing agents, epoxy resins, engineering plastics, dyestuffs, polysulfone amides, and other polymers; monomer for polysulfonamide fiber; and pharmaceutical and auxiliary intermediates. It also exports its products to Europe, the United States, Japan, Korea, Taiwan, and Hong Kong. The company was founded in 2003 and is headquartered in Cangzhou, China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 658.21M | 742.47M | 628.15M | 563.71M | 925.16M | 1.42B | 535.88M | 331.19M | 415.55M | 466.35M | 411.31M | 351.71M | 305.83M | 302.06M | 232.10M | 257.83M | 188.78M |
Cost of Revenue | 579.62M | 625.27M | 555.85M | 447.14M | 464.58M | 513.64M | 357.72M | 263.31M | 333.99M | 353.09M | 299.88M | 287.81M | 245.89M | 214.35M | 156.32M | 197.82M | 158.27M |
Gross Profit | 78.60M | 117.20M | 72.30M | 116.57M | 460.57M | 904.66M | 178.16M | 67.88M | 81.56M | 113.27M | 111.44M | 63.90M | 59.94M | 87.71M | 75.79M | 60.01M | 30.51M |
Gross Profit Ratio | 11.94% | 15.78% | 11.51% | 20.68% | 49.78% | 63.78% | 33.25% | 20.50% | 19.63% | 24.29% | 27.09% | 18.17% | 19.60% | 29.04% | 32.65% | 23.28% | 16.16% |
Research & Development | 35.15M | 31.81M | 28.27M | 24.82M | 37.66M | 49.49M | 17.35M | 13.46M | 10.87M | 8.17M | 7.62M | 7.97M | 1.95M | 1.65M | 894.27K | 680.72K | 292.00K |
General & Administrative | 22.28M | 13.64M | 12.65M | 14.59M | 18.00M | 25.65M | 16.56M | 14.11M | 14.56M | 25.11M | 25.36M | 20.85M | 15.65M | 8.00M | 7.11M | 7.02M | 2.33M |
Selling & Marketing | 1.86M | 3.22M | 3.80M | 3.68M | 6.86M | 9.18M | 7.11M | 6.57M | 6.33M | 6.06M | 6.39M | 6.27M | 6.06M | 4.85M | 4.55M | 4.70M | 4.77M |
SG&A | 24.14M | 16.86M | 16.45M | 18.26M | 24.86M | 34.83M | 23.68M | 20.69M | 20.89M | 31.16M | 31.75M | 27.12M | 21.71M | 12.85M | 11.66M | 11.73M | 7.10M |
Other Expenses | 5.01M | -505.82K | 460.43K | -9.29M | -1.99M | -22.08M | -5.99M | 1.74M | 1.16M | 909.45K | 599.90K | -232.57K | -9.18K | 206.76K | 700.00K | -975.69K | 6.10K |
Operating Expenses | 64.30M | 73.76M | 79.22M | 80.29M | 117.88M | 149.42M | 75.97M | 60.36M | 61.47M | 70.58M | 67.29M | 53.14M | 42.83M | 28.13M | 23.79M | 19.76M | 11.16M |
Cost & Expenses | 643.92M | 699.02M | 635.07M | 527.43M | 582.46M | 663.06M | 433.69M | 323.67M | 395.46M | 423.67M | 367.17M | 340.95M | 288.72M | 242.48M | 180.10M | 217.57M | 169.43M |
Interest Income | 13.90M | 12.26M | 12.75M | 26.77M | 30.13M | 7.90M | 1.84M | 2.97M | 3.37M | 3.66M | 4.82M | 5.37M | 10.50M | 3.97M | 46.01K | 81.21K | 2.91K |
Interest Expense | 436.02K | 757.64K | 551.01K | 489.08K | 167.88K | 18.43M | 194.89K | 5.11M | 197.05K | 55.54K | 157.81K | 217.97K | 56.17K | 549.37K | 1.96M | 4.16M | 1.13M |
Depreciation & Amortization | 65.36M | 65.78M | 67.54M | 62.79M | 53.45M | 52.14M | 52.50M | 52.67M | 51.11M | 47.23M | 42.66M | 32.18M | 14.50M | 12.72M | 10.04M | 10.43M | 9.86M |
EBITDA | 79.09M | 130.85M | 80.27M | 113.75M | 397.35M | 807.03M | 154.69M | 62.99M | 77.83M | 95.49M | 85.05M | 46.36M | 39.13M | 74.78M | 62.12M | 48.14M | 29.72M |
EBITDA Ratio | 12.02% | 17.82% | 12.36% | 20.17% | 42.95% | 56.95% | 29.66% | 17.34% | 20.10% | 20.86% | 22.17% | 13.62% | 13.37% | 24.96% | 26.90% | 17.91% | 13.93% |
Operating Income | 14.29M | 64.73M | 11.55M | 59.47M | 380.28M | 787.59M | 107.95M | 24.26M | 27.56M | 47.77M | 46.17M | 14.19M | 24.58M | 61.30M | 49.18M | 31.73M | 15.80M |
Operating Income Ratio | 2.17% | 8.72% | 1.84% | 10.55% | 41.10% | 55.53% | 20.14% | 7.32% | 6.63% | 10.24% | 11.22% | 4.03% | 8.04% | 20.29% | 21.19% | 12.31% | 8.37% |
Total Other Income/Expenses | -859.89K | -505.82K | 460.43K | -9.29M | -1.99M | -22.08M | -5.99M | 1.72M | -837.09K | 434.36K | -3.41M | -232.57K | 9.23M | 206.76K | -1.61M | -9.40M | 6.10K |
Income Before Tax | 13.43M | 64.22M | 12.01M | 50.18M | 378.29M | 765.50M | 101.97M | 25.97M | 26.72M | 48.20M | 42.76M | 13.96M | 24.57M | 61.51M | 49.83M | 30.02M | 15.81M |
Income Before Tax Ratio | 2.04% | 8.65% | 1.91% | 8.90% | 40.89% | 53.97% | 19.03% | 7.84% | 6.43% | 10.34% | 10.40% | 3.97% | 8.03% | 20.36% | 21.47% | 11.64% | 8.38% |
Income Tax Expense | -1.30M | 2.95M | -1.63M | 4.84M | 52.78M | 109.49M | 14.89M | 3.22M | 3.57M | 7.63M | 6.63M | 2.08M | 3.71M | 9.23M | 7.77M | 7.76M | 5.17M |
Net Income | 14.73M | 61.27M | 13.64M | 45.41M | 325.58M | 656.01M | 87.08M | 22.75M | 23.15M | 40.58M | 36.13M | 11.88M | 20.85M | 52.28M | 42.06M | 22.26M | 10.64M |
Net Income Ratio | 2.24% | 8.25% | 2.17% | 8.06% | 35.19% | 46.25% | 16.25% | 6.87% | 5.57% | 8.70% | 8.78% | 3.38% | 6.82% | 17.31% | 18.12% | 8.63% | 5.64% |
EPS | 0.03 | 0.11 | 0.02 | 0.08 | 0.59 | 1.20 | 0.16 | 0.04 | 0.04 | 0.08 | 0.14 | 0.02 | 0.04 | 0.10 | 0.11 | 0.06 | 0.03 |
EPS Diluted | 0.03 | 0.11 | 0.02 | 0.08 | 0.59 | 1.18 | 0.16 | 0.04 | 0.04 | 0.07 | 0.14 | 0.02 | 0.04 | 0.10 | 0.11 | 0.06 | 0.03 |
Weighted Avg Shares Out | 551.80M | 551.73M | 551.73M | 549.73M | 547.81M | 546.86M | 544.90M | 541.73M | 538.39M | 533.94M | 267.37M | 527.45M | 520.77M | 444.46M | 400.10M | 395.32M | 404.97M |
Weighted Avg Shares Out (Dil) | 573.27M | 557.04M | 551.73M | 550.40M | 554.93M | 556.04M | 546.61M | 541.73M | 564.65M | 555.88M | 267.37M | 527.45M | 520.77M | 444.46M | 400.10M | 395.32M | 404.97M |
Source: https://incomestatements.info
Category: Stock Reports